Schedule iii

The U.S. Department of Justice issued an order on April 23, 2026, rescheduling certain cannabis products to Schedule III - a development that, for qualifying medical operators, ends the application

A signed order by Acting Attorney General Todd Blanche last month reclassified state-licensed medical cannabis to Schedule III under the Controlled Substances Act - a shift that immediately